A consolidated view of Neodocs publications, validation studies, and regulatory support across kidney health and haemoglobin screening workflows.
Both uACR and HB are represented here with CDSCO support notes or certification references.
The evidence set includes ICMR-supported references for both uACR and haemoglobin workflows.
uACR
Clinical publications, pilot studies, and hospital-based validation work supporting early CKD screening in India.
The uACR kit is also supported by ICMR and ICMR Center of Excellence programs.
The uACR kit is listed here as CDSCO approved.
Authors
Neodocs team; Dr Ateeb Sheikh
Brief
This evaluation compared Neodocs test cards with the Acon Mission U120 urine analyzer across 14 urine biomarkers. The study reported strong performance for rapid detection of important health indicators, with notable accuracy and reliability.
Authors
Neodocs team; Dr Rohit Srivastava; Dr Vijay Kher; Dr Ajay Kher
Brief
The study showed that the Neodocs strip paired with the app can accurately classify the vast majority of screened patients into A1 versus A2/A3 categories, enabling earlier referral for evaluation and management.
Authors
Neodocs team; Mudit Sabharwal; Seema Bagri; Soumik Goswami; Apurv Parekh; Debmalya Saniyal; Bharat Saboo; Subodh Banzal; Abhyudaya Verma; BS Shah; Satyam Chakraborty; Sayantan Chakraborty; Chandreshkumar Sudani; Pratyush Kumar
Brief
This study evaluated CKD prevalence in high-risk individuals using the Neodocs uACR kit, with emphasis on diabetes and hypertension. The findings describe a high CKD burden, especially in patients living with both conditions together.
Authors
Neodocs team; Mudit Sabharwal
Brief
In 94 hospital patients, this study evaluated the Neodocs point-of-care card for microalbuminuria detection using uACR against a reference analyzer. The device showed 91.23% sensitivity, 94.7% specificity, and good agreement with the reference method.
Authors
Rama Krishna Chinta; Venkateswar Shri; Bogdan Milojkovic; Dennis Begos; Shyamala Kemisetti; Naresh Kumar Chintagunti; Boris Bikbov; FOCUS-CKD Project
Brief
This pilot study assessed point-of-care testing and digital health for CKD screening in high-risk urban and rural populations in Andhra Pradesh. Screening of 2,060 participants found high CKD prevalence with very low awareness, supporting scale-up of POCT-based screening.
Authors
Ateeb Shaikh; Sameer Baluni; Nikunj Malpani; Pratik Lodha; Anurag Meena
Brief
In a randomized controlled trial, an AI-driven metabolic coaching intervention combined with point-of-care monitoring, including POCT uACR screening, significantly improved glycemic control compared with standard care and supported earlier kidney risk detection.
Evidence summary
Across community, hospital, and diabetes care settings, the listed studies position Neodocs uACR screening as a practical tool for earlier CKD risk detection and triage.
CKD screening, microalbuminuria detection, diabetes-linked kidney risk, hypertension-linked kidney risk, and point-of-care workflow adoption.
Neodocs combines urine strip chemistry with app-assisted interpretation to make uACR screening faster and more accessible beyond conventional lab settings.
Haemoglobin
Validation data and supporting publications for the Neodocs haemoglobin point-of-care testing workflow.
HB is also supported by ICMR.
HB also has a CDSCO certificate.
Authors
Not listed in provided note
Brief
Validation material provided for the Neodocs haemoglobin workflow.
Authors
Not listed in provided note
Brief
Study material provided for Neodocs haemoglobin testing validation.
Authors
Neodocs Team; Shubham Munde
Brief
A validation study evaluated a point-of-care haemoglobin testing device designed to support anemia screening under India’s Anemia Mukt Bharat program. The device showed high precision, reproducibility (SD ≤0.57), and strong agreement with a standard laboratory hematology analyzer, accurately detecting moderate-to-severe anemia.
Evidence summary
The listed haemoglobin evidence supports Neodocs Hb testing as a rapid and reliable point-of-care option for anemia screening programs and field use.
Anemia screening, point-of-care haemoglobin testing, reproducibility, laboratory agreement, and large-scale public health deployment.
The Neodocs Hb workflow is positioned for quick screening in clinical and community settings where fast decision support and portable testing matter.
